ENTITY
Giant Biogene

Giant Biogene (2367 HK)

167
Analysis
Consumer Staples • China
Giant Biogene designs, develops, manufactures, and sells beauty and health products, primarily functional skincare products and medical dressings, utilizing recombinant collagen as a key bioactive ingredient. The company also develops and manufactures functional foods based on rare ginsenosides technology. It was founded in 2000 and is headquartered in Xi'an, People's Republic of China.
more
bearish•Honasa Consumer
•02 May 2024 10:45

Honasa Consumer IPO Lock-Up Expiry - US$500m+ Lockup Expiry with Everyone Well in the Money

Honasa Consumer (HONASA IN) raised about US$200m in its India IPO. Its pre-IPO investors will be released from its IPO linked lockup soon.

Logo
403 Views
Share
bullish•Mao Geping Cosmetics
•30 Apr 2024 08:55

Pre-IPO Mao Geping Cosmetics - Potential Risks Behind High Gross Margins

Despite high gross margin, ​MAO GEPING's heavy reliance on its flagship brand and founder could pose risks. Lack of innovation and over-reliance on...

Logo
701 Views
Share
•30 Apr 2024 03:08

L’Occitane (973 HK): Conditional VGO at HK$34

The key condition is that the offeror holds at least 90% of the disinterested shares. An attractive offer (representing an all-time high) should...

Logo
648 Views
Share
bullish•Mao Geping Cosmetics
•18 Apr 2024 07:00

Mao Geping Cosmetics Pre-IPO Tearsheet

Mao Geping Cosmetics (1478187D CH) is looking to raise around US$300m in its upcoming Hong Kong IPO. The bookrunner on the deal is CICC.

Logo
801 Views
Share
•09 Apr 2024 13:19

L’Occitane (973 HK): Blackstone Pondering an Offer

L’Occitane is on a trading halt pursuant to the Code on Takeovers and Mergers. Bloomberg reports that Blackstone is nearing a privatisation deal...

Logo
1.1k Views
Share
x